![Rune Blomhoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rune Blomhoff
Corporate Officer/Principal bei University of Oslo
Aktive Positionen von Rune Blomhoff
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Oslo | Corporate Officer/Principal | - | - |
Karriereverlauf von Rune Blomhoff
Ehemalige bekannte Positionen von Rune Blomhoff
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cgene AS
![]() Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Vorsitzender | 22.04.1985 | - |
Gründer | 22.04.1985 | - |
Statistik
International
Norwegen | 3 |
Operativ
Corporate Officer/Principal | 1 |
Chairman | 1 |
Founder | 1 |
Sektoral
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cgene AS
![]() Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Commercial Services |
- Börse
- Insiders
- Rune Blomhoff
- Erfahrung